Picton Mahoney Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,700
Closed -$36.8M 977
2024
Q4
$36.8M Buy
+47,700
New +$39.5M 0.75% 17

Other funds holding LLY

Picton Mahoney Asset Management's LLY Position: Q1 2026 in Review

Picton Mahoney Asset Management reduced its Eli Lilly (LLY) stake by 20% in Q1 2026, selling an estimated $8.5M and leaving 32,987 shares worth $30.3M. The position accounts for 0.22% of the portfolio, ranked #70.

Picton Mahoney Asset Management first reported a position in LLY in Q3 2013 and has held it in 23 quarters since. The position peaked at $44.5M in Q4 2025. 4,366 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Picton Mahoney Asset Management held 32,987 shares of Eli Lilly worth $30.3M as of Q1 2026.
  • Picton Mahoney Asset Management sold 8,385 Eli Lilly shares in Q1 2026, an estimated $8.5M.
  • Eli Lilly made up 0.22% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #70 holding.
  • Picton Mahoney Asset Management first reported a position in Eli Lilly in Q3 2013 and has held it in 23 quarters since.
  • Picton Mahoney Asset Management's Eli Lilly position peaked at $44.5M in Q4 2025.
  • 4,366 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.